Clinical Trials Logo

Shock clinical trials

View clinical trials related to Shock.

Filter by:

NCT ID: NCT02535949 Completed - Hemorrhage Clinical Trials

Tranexamic Acid Mechanisms and Pharmacokinetics in Traumatic Injury

TAMPITI
Start date: February 2016
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the effects of TXA on the immune system, its pharmacokinetics, as well as safety and efficacy in severely injured trauma patients.

NCT ID: NCT02519699 Completed - Septic Shock Clinical Trials

Microcirculation After MAP Increase in Septic Shock Patients With Previous Hypertension

Start date: March 2013
Phase: Phase 4
Study type: Interventional

The optimal levels of mean arterial pressure that must be achieved in septic shock are subject of debate. Studies tried to correlate blood pressure increase in patients with septic shock with microcirculation. However, there are few studies that specifically assessed septic shock patients with previous arterial hypertension. The main objective of this study is to evaluate the effect of increased blood pressure level in the microcirculation of these patients and compare them with patients without arterial hypertension.

NCT ID: NCT02505646 Completed - Circulatory Failure Clinical Trials

Fluid Responsiveness Evaluation by AbdomiNal Compression in Kids Based on the STARLING Concept

FRANCK
Start date: July 2015
Phase: N/A
Study type: Observational

Purpose: Fluid responsiveness in a context of circulatory failure can be predicted by different way. Dynamic criteria such as pulse pressure variation, stroke volume variation during an end-expiratory occlusion maneuver or a passive leg raising have been reported to predict fluid responsiveness. Only aortic velocity peak variation measured with transthoracic echocardiography during mechanical ventilation has been reported to predict fluid responsiveness in children. Besides some physician use a maneuver of abdominal compression to predict fluid responsiveness in children with circulatory failure. This strategy has never been formally evaluated. The investigators will study the diagnosis accuracy of the stroke volume variation induced by an abdominal compression to predict stroke volume variation after 10 ml/kg fluid load in children with circulatory failure. Thirty-eight pediatric patients under eight years old in circulatory failure, for whom the attending physician has decided a fluid load will be included. Hemodynamic parameters: arterial pressure, heart rate, stroke volume measured with echocardiography; will be recorded. This data collection will be performed before, after abdominal compression and after a fluid load of 10 ml/kg. Patients will be aposteriori sorted in two groups: Fluid responders and Fluid non-responders. Fluid responders are defined as patients that show an increase greater than 15 % in stroke volume. The diagnosis ability of the Stroke volume variation after an abdominal compression to predict fluid responsiveness will be investigate and receiving operative characteristic (ROC) curve will be built. The correlation between the variation of stroke volume during abdominal compression and during the fluid load will be studied. Other parameters such as arterial pressure and heart rate will also be investigated.

NCT ID: NCT02473718 Completed - Septic Shock Clinical Trials

Fluid Balance in the ICU - Interventions to Minimize Fluids in Patients With Septic Shock

Start date: January 2014
Phase: N/A
Study type: Interventional

The purpose of the study is to determine if a protocol that assesses patients' daily fluid intake and output can decrease the overall amount of fluid patients receive during the first five days in the ICU. The study will also determine if decreasing overall fluids can decrease adverse events associated with mechanical ventilation, such as ventilator-associated pneumonias. The protocol will include daily ultrasounds and blood draws to evaluate fluid balance. Ultrasound will be used to measure changes in the diameter of the inferior vena cava with respiration.

NCT ID: NCT02473263 Completed - Clinical trials for Severe Septic Syndrome (Severe Sepsis and Septic Shock) Diagnosed and Treated by Mobile Intensive Care Unit

Samu Save Sepsis: Early Goal Directed Therapy in Pre Hospital Care of Patients With Severe Sepsis and/or Septic Shock

SSS
Start date: May 9, 2016
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine whether an aggressive strategy of severe sepsis patients since pre hospital care, including early antibiotics administration, hemodynamic optimization, and opotherapy when indicated, could reduce mortality

NCT ID: NCT02468063 Completed - Clinical trials for Cirrhosis With Septic Shock

To Assess the Efficacy of Early Introduction of a Combination of Low Dose Vasopressin Analogue in Addition to Noradrenaline as a Vasopressor in Patients of Cirrhosis With Septic Shock

Start date: May 1, 2015
Phase: N/A
Study type: Interventional

The consecutive patients admitted to Intensive care unit of Hepatology department of ILBS and full filling all the eligibility criteria will be enrolled in 1:1 ration by the process of randomization.- The study is an open level study. The investigators will strictly follow the randomization table to give therapy as per the intervention arm. - Intervention:-the therapeutic intervention is vasopressor i.e. noradrenaline alone and terlipressin along with noradrenaline to maintain the MAP >65mm Hg. - Intervention arm - Arm (A) - Noradrenaline - Arm (B) - Noradrenaline + low dose terlipressin

NCT ID: NCT02453425 Completed - Acute Kidney Injury Clinical Trials

The Effects of Blood Pressure on Renal Function and Oxygenation in Septic Shock

Start date: May 2011
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate renal effects of 3 different levels of mean arterial pressure in early case of septic shock. In 8 patients diagnosed with early septic shock, we will adjust mean arterial pressure (MAP) to three different levels, using norepinephrine. At each level of MAP, central and renal hemodynamics and oxygenation states will be measured. Analysis will be made to describe the pathophysiology at MAP 75 mmHg, and then to evaluate at which MAP renal function and oxygenation is least affected negatively.

NCT ID: NCT02442440 Completed - Septic Shock Clinical Trials

Anisodamine Critically Ill SeptIc Shock

ACIdoSIS
Start date: April 2015
Phase: Phase 1/Phase 2
Study type: Interventional

Anisodamine has been widely used in China for its pharmacological effect on improving microcirculation during shock. It has been reported that anisodamine is effective in reducing mortality rate in children with meningitis. however, its effectiveness in patients with septic shock has not been systematically investigated. The aim of the study is to investigate the effectiveness of anisodamine in the treatment of patients with septic shock.

NCT ID: NCT02424136 Completed - Anaphylaxis Clinical Trials

PEAnut Anaphylaxis Predictors

PEAAP
Start date: July 22, 2015
Phase: N/A
Study type: Interventional

Peanut allergy can be life-threatening. Current diagnostic techniques for peanut allergy have high sensitivity, but not high specificity. This clinical trial will test the validity of a novel blood biomarker (compared with current testing) as a diagnostic predictor of anaphylaxis to peanut.

NCT ID: NCT02421484 Completed - Septic Shock Clinical Trials

Cellular Immunotherapy for Septic Shock: A Phase I Trial

CISS
Start date: May 2015
Phase: Phase 1
Study type: Interventional

This is a Phase I open label dose escalation trial of human allogeneic bone marrow derived mesenchymal stromal cells (MSCs) for the treatment of septic shock. The main purpose of the study is to assess the safety of MSCs in patients with septic shock.